MediFit’s Post

It's no secret that the ubiquitous GLP1 weight loss drug on the market has taken over discussions around water coolers across this nation. If you are overweight, obese, or a type 2 diabetic, you've at least considered starting a weight-loss injectable. And why not? It is a viable solution for those with dangerously resistant metabolic syndrome and excess weight that just doesn't seem to melt off, no matter what you do to intervene. No drug is full-proof. However, this peptide, injected once a week, is changing the health of this nation for the better when coupled with positive and consistent lifestyle changes. As a Brainz Magazine executive contributor, I seek to educate you about various natural and medical interventions to help you live your healthiest life. Read: 4 mins #glp1 #medicalweightloss #weightlossinjection

Revolutionize weight loss with Approved Medical Solutions GLP-1 products! When GLP-1 has been all the rage with weight loss solutions, it's time to offer your patients an alternative solution, or an "in-between" product for when they are between prescriptions. The Approved Medical Solutions System is designed to help with intermittent fasting. Intermittent fasting allows your body to not be distracted with digesting food and allows amazing cellular repair to take place which can lead to reduced hunger and blood sugar levels, and weight loss. Talk to your POA rep if you'd like to offer your patients a weight loss solution!

Discover a New Path to Weight Loss! 🌟 Our GLP-1 Semaglutide & Tirzepatide program is physician-guided, with medications shipped to your door. Consultations begin at just $99! #Semaglutide #WeightLoss #WeightLossSolutions

GLP-1 agonists like Wegovy and Zepbound continue to rise in popularity, adding fuel to the fiery debate over the government’s role in subsidizing access to these drugs, especially for weight management.     Curious about which state Medicaid programs currently cover #GLP1s for #obesity and how much are they spending? Understanding the full landscape is essential for staying competitive in this rapidly evolving market. Our experts have you covered. Dive into our latest report using data from IRIS – Real Chemistry’s market intelligence platform – for the full breakdown: https://bit.ly/49EpDPt  

🌟 Exploring Medicaid Coverage for #GLP1 Treatments Across the U.S. 🌟 A recent analysis by Real Chemistry provides an in-depth look at state Medicaid programs covering GLP-1 receptor agonists for obesity—a condition affecting over 40% of U.S. adults. These drugs, originally for #Type2diabetes, have proven effective for #weightloss, but costs can exceed $1,000 monthly, making #insurance coverage crucial. 🔍 Key Findings: - Coverage Variability: 36 states cover at least one #FDA-approved GLP-1 for obesity, like #Wegovy or #Zepbound. However, coverage levels vary significantly. - Spending Surge: #Medicaid spending on these treatments has skyrocketed, with $3.5 billion spent over the past year. California leads with $1.4 billion in expenditures. - Policy Implications: With the Biden administration’s proposal to expand coverage, understanding current state policies and spending is essential. 🏥 This analysis underscores the need for broader access to obesity treatments, highlighting disparities and potential growth in Medicaid spending. As health policies evolve, ensuring #equitableaccess remains a critical challenge. 📈 For more insights, read the full analysis on Real Chemistry's website. #Healthcare #ObesityTreatment #HealthPolicy #RealChemistry

Our focus on the price of weight loss medication is blinding us. Instead, we should talk more about this. → Dosage and time. Since its launch, GLP-1 medication like Novo Nordisk’s Wegovy has been criticised for its relatively high price point. While the price of medication is an important topic (affordability leads to access), there’s too little focus on these two parameters that — in the case of weight loss medication — matter just as much. Turns out, you don’t need the full 2.4 mg standard dose or life-long treatment to see meaningful, lasting results. According to our real-world Embla study, there’s a way to get better outcomes out of less medication. This means the average user can save on medicine costs and experience fewer side effects. Additionally, this approach helps the global supply last longer. I discuss this, and more, in an opinion piece in Jyllands-Posten. Link in comments 👇 #wegovy #semaglutide #obesity #weightmanagement #weightloss

ACCUNIQ BP250 Designed to be convenient, easy-to-use, and to provide reliable results. These highly advanced blood pressure monitors make it easy to keep track of patient data and information. They also print out the results of the analysis. for more information: info@beamedtrading.com #medicaldevice #medicaldevices #medicaldevicesales #medicaldevicesafety #medicaldevicecompany #medicaldevicereprocessing #medicaldeviceregulation #medicaldevicedistributor #medicaldevicecase #medicaldevicebusiness #medicaldevicestore

Evaluate how much medication is required to start and maintain enrolment. Predict how long medication will last. Determine optimal buffer stock needed. And reduce excessive drug wastage. All with Calyx’s Supply Simulation service. https://lnkd.in/gmvgSXTb #IRT #RTSM #TrialSupplyManagement #ChooseCalyx

🚀 The rise of GLP-1 medications is transforming the medical weight loss industry, creating opportunities for innovative programs to thrive. To stand out, you need more than just a great offering—you need a strategic plan! Our essential checklist reveals 7 crucial tips for developing a program that meets client needs, attracts new patients and ensures lasting success. Ready to elevate your weight loss program? Download our checklist and get started today! https://bit.ly/4dUivzQ #WeightLoss #HealthcareMarketing #PatientRetention #GLP1Medications #StrategicPlanning